** U.S.-listed shares of Brazilian medical education group
AFYA.O rise as much as 14.2% at $25
** Co set for its best day since market debut on Jul. 19, if
gains hold
** Co expects pro forma FY rev to be between R$817.2 mln
($198.37 million) and R$832.2 mln vs est. of R$814.1 mln -
Refinitiv data
** Sees FY adj. EBITDA to be in the range of R$308.1 mln to
R$322.4 mln, way ahead of the R$299 mln est.
** Co also expects pro forma net rev. for second half of
2019 to be between R$415 mln and R$430 mln
** "We expect to improve efficiencies and extract synergies
of companies acquired along 2Q19 (FASA and IPEMED), which is
expected to improve revenues and margins of such companies in
2H19"- co urn:newsml:reuters.com:*:nGNX7pDlyS
** AFYA fell nearly 30% on Aug. 30 after Q2 profit fell
urn:newsml:reuters.com:*:nL3N25Q4FM
** Among top percentage gainers across U.S. exchanges
** Stock gained nearly 32% in value from IPO price of
$19/shr
($1 = 4.1196 reais)
(Reporting by C Nivedita in Bengaluru)
((C.Nivedita@thomsonreuters.com))